Literature DB >> 7811055

Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion.

K M Wasan1, V B Grossie, G Lopez-Berestein.   

Abstract

The influences of Intralipid (IL) and 0.45% normal-saline infusions on the concentration in serum and distribution in tissue of amphotericin B (AmpB) and liposomal amphotericin B (L-AmpB) in rats were compared. In animals receiving a continuous IL infusion, concentrations of AmpB in kidneys and lungs were significantly higher, but the concentration of AmpB in serum was significantly lower in animals administered AmpB versus those given L-AmpB. In animals receiving a continuous normal-saline infusion concentrations of AmpB in kidneys and the spleen were significantly higher, but the concentration of AmpB in serum was significantly lower in animals administered AmpB versus those given L-AmpB. These results suggest that the increased total serum cholesterol and high-density lipoprotein cholesterol during the IL infusion decreased the clearance of AmpB from the bloodstream and decreased the L-AmpB concentration in the kidney and lung.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811055      PMCID: PMC284720          DOI: 10.1128/AAC.38.9.2224

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Treatment of systemic fungal infections with liposomal amphotericin B.

Authors:  G Lopez-Berestein; G P Bodey; V Fainstein; M Keating; L S Frankel; B Zeluff; L Gentry; K Mehta
Journal:  Arch Intern Med       Date:  1989-11

2.  Alteration of lipoprotein profile during total parenteral nutrition with intralipid 10%.

Authors:  T Tashiro; Y Mashima; H Yamamori; K Okui
Journal:  JPEN J Parenter Enteral Nutr       Date:  1986 Nov-Dec       Impact factor: 4.016

3.  Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B.

Authors:  G Lopez-Berestein; R Mehta; R L Hopfer; K Mills; L Kasi; K Mehta; V Fainstein; M Luna; E M Hersh; R Juliano
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

4.  Synthetic high density lipoprotein particles. Application to studies of the apoprotein specificity for selective uptake of cholesterol esters.

Authors:  R C Pittman; C K Glass; D Atkinson; D M Small
Journal:  J Biol Chem       Date:  1987-02-25       Impact factor: 5.157

5.  Identification of lipoprotein X-like particles in rat plasma following Intralipid infusion.

Authors:  W C Breckenridge; G Kakis; A Kuksis
Journal:  Can J Biochem       Date:  1979-01

6.  Effects of intralipid infusion on rat serum lipoproteins.

Authors:  K M Wasan; V B Grossie; G Lopez-Berestein
Journal:  Lab Anim       Date:  1994-04       Impact factor: 2.471

7.  An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis.

Authors:  R Kirsh; R Goldstein; J Tarloff; D Parris; J Hook; N Hanna; P Bugelski; G Poste
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

8.  Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patients.

Authors:  G G Chabot; R Pazdur; F A Valeriote; L H Baker
Journal:  J Pharm Sci       Date:  1989-04       Impact factor: 3.534

9.  Changes of high density lipoprotein subfraction concentration and composition by intralipid in vivo and by lipolysis of intralipid in vitro.

Authors:  M R Taskinen; E A Nikkilä; T Kuusi; I Tulikoura
Journal:  Arteriosclerosis       Date:  1983 Nov-Dec

10.  Altered tissue distribution of amphotericin B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans.

Authors:  G Lopez-Berestein; M G Rosenblum; R Mehta
Journal:  Cancer Drug Deliv       Date:  1984
View more
  20 in total

1.  Lipoprotein distribution of a novel endotoxin antagonist, E5531, in plasma from human subjects with various lipid levels.

Authors:  K M Wasan; F W Strobel; S C Parrott; M Lynn; W J Christ; L D Hawkins; D P Rossignol
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

Review 2.  Role of plasma lipoproteins in modifying the toxic effects of water-insoluble drugs: studies with cyclosporine A.

Authors:  Kishor M Wasan; Manisha Ramaswamy; Mona Kwong; Kathy D Boulanger
Journal:  AAPS PharmSci       Date:  2002

3.  Differences in lipoprotein concentration and composition modify the plasma distribution of free and liposomal annamycin.

Authors:  K M Wasan; R E Morton
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

4.  Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models.

Authors:  Faisal Usman; Jongdee Nopparat; Ibrahim Javed; Teerapol Srichana
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

5.  Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients.

Authors:  V Heinemann; D Bosse; U Jehn; B Kähny; K Wachholz; A Debus; P Scholz; H J Kolb; W Wilmanns
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

6.  Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children.

Authors:  Jodi M Lestner; Andreas H Groll; Ghaith Aljayyoussi; Nita L Seibel; Aziza Shad; Corina Gonzalez; Lauren V Wood; Paul F Jarosinski; Thomas J Walsh; William W Hope
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

7.  Evaluation of renal toxicity and antifungal activity of free and liposomal amphotericin B following a single intravenous dose to diabetic rats with systemic candidiasis.

Authors:  K M Wasan; J S Conklin
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

8.  Effect of intralipid infusion on serum high- and low-density lipoprotein cholesterol, lecithin:cholesterol acyltransferase, and lipoprotein lipase in tumor-bearing rats.

Authors:  K M Wasan; V B Grossie
Journal:  Experientia       Date:  1995-03-15

9.  Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies.

Authors:  K M Wasan; A L Kennedy; S M Cassidy; M Ramaswamy; L Holtorf; J W Chou; P H Pritchard
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats.

Authors:  Verica Risovic; Michael Boyd; Eugene Choo; Kishor M Wasan
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.